IWP
ARNA

IAG Wealth Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

IAG Wealth Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-92
Closed -$9K – 481
2021
Q4 		$9K Hold
92
– – ﹤0.01% 316
2021
Q3 		$6K Hold
92
– – ﹤0.01% 321
2021
Q2 		$7K Hold
92
– – ﹤0.01% 302
2021
Q1 		$7K Hold
92
– – ﹤0.01% 296
2020
Q4 		$8K Hold
92
– – ﹤0.01% 271
2020
Q3 		$7K Hold
92
– – ﹤0.01% 268
2020
Q2 		$6K Hold
92
– – ﹤0.01% 279
2020
Q1 		$4K Buy
+92
New +$4.22K ﹤0.01% 294

IAG Wealth Partners's ARNA Position: Q1 2022 in Review

IAG Wealth Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 92 shares — an estimated $9K sold.

IAG Wealth Partners first reported a position in ARNA in Q1 2020 and held it in 8 quarters. The position peaked at $9K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • IAG Wealth Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • IAG Wealth Partners sold 92 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $9K.
  • IAG Wealth Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 8 quarters.
  • IAG Wealth Partners's Arena Pharmaceuticals Inc position peaked at $9K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on IAG Wealth Partners's 13F filing for Q1 2022, filed 4 May 2022.